文献速递眼底病与葡萄膜炎

视网膜巨噬细胞合成C3并在年龄相关性黄斑变性和局灶性视网膜变性模型中激活补体

Retinal Macrophages Synthesize C3 and Activate Complement in AMD and in Models of Focal Retinal Degeneration.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

研究在人类AMD供体视网膜及大鼠、小鼠局灶性视网膜变性模型中探究视网膜小胶质细胞/巨噬细胞局部产生C3对补体激活和变性的作用。结果显示AMD眼外层视网膜小胶质细胞/巨噬细胞表达C3,局部抑制C3可抑制补体激活并减少细胞死亡,而全身清除血清补体无效。作者认为局部产生的C3因果性参与视网膜变性,C3靶向基因治疗可能有助于延缓AMD进展。

要点

  • AMD眼外层视网膜小胶质细胞/巨噬细胞表达C3。
  • 局部抑制C3可抑制补体激活和沉积并减少细胞死亡。
  • 全身清除血清补体对光氧化损伤后视网膜变性无影响。

核心结论

  • 局部由视网膜小胶质细胞/巨噬细胞产生的C3因果性参与视网膜变性
  • 作者认为C3靶向基因治疗可能有助于延缓AMD进展

研究设计与样本

  • 人类AMD供体视网膜通过原位杂交标记C3表达
  • 大鼠接受光氧化损伤并以OCT追踪病灶扩展2个月
  • 小鼠采用三种策略:C3基因完全敲除、玻璃体内注射siRNA局部抑制C3、眼镜蛇毒因子清除血清C3

主要发现

  • AMD眼外层视网膜小胶质细胞/巨噬细胞表达视网膜C3
  • 啮齿类光氧化损伤后2个月内,表达C3的小胶质细胞/巨噬细胞及补体激活位于外层视网膜病灶扩展区域
  • C3基因完全敲除改善损伤后视网膜变性和补体激活,而全身清除血清补体无影响
  • siRNA局部抑制C3表达抑制补体激活和沉积并减少细胞死亡

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Complement system dysregulation is strongly linked to the progression of age-related macular degeneration (AMD). Deposition of complement including C3 within the lesions in atrophic AMD is thought to contribute to lesion growth, although the contribution of local cellular sources remains unclear. We investigated the role of retinal microglia and macrophages in complement activation within atrophic lesions, in AMD and in models of focal retinal degeneration. METHODS: Human AMD donor retinas were labeled for C3 expression via in situ hybridization. Rats were subject to photo-oxidative damage, and lesion expansion was tracked over a 2-month period using optical coherence tomography (OCT). Three strategies were used to determine the contribution of local and systemic C3 in mice: total C3 genetic ablation, local C3 inhibition using intravitreally injected small interfering RNA (siRNA), and depletion of serum C3 using cobra venom factor. RESULTS: Retinal C3 was expressed by microglia/macrophages located in the outer retina in AMD eyes. In rodent photo-oxidative damage, C3-expressing microglia/macrophages and complement activation were located in regions of lesion expansion in the outer retina over 2 months. Total genetic ablation of C3 ameliorated degeneration and complement activation in retinas following damage, although systemic depletion of serum complement had no effect. In contrast, local suppression of C3 expression using siRNA inhibited complement activation and deposition, and reduced cell death. CONCLUSIONS: These findings implicate C3, produced locally by retinal microglia/macrophages, as contributing causally to retinal degeneration. Consequently, this suggests that C3-targeted gene therapy may prove valuable in slowing the progression of AMD.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Natoli R, Fernando N, Jiao H, et al. Retinal Macrophages Synthesize C3 and Activate Complement in AMD and in Models of Focal Retinal Degeneration. Invest Ophthalmol Vis Sci. 2017. PMID: 28605809. doi:10.1167/iovs.17-21672

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。